Norges Bank Madrigal Pharmaceuticals, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$193.33 - $291.99 $22.4 Million - $33.9 Million
116,027 New
116,027 $32.5 Million
Q4 2023

Feb 09, 2024
BUY
$120.4 - $237.13 $17.5 Million - $34.5 Million
145,589 New
145,589 $33.7 Million
Q3 2023

Nov 13, 2024
BUY
$146.04 - $225.78 $22.1 Million - $34.1 Million
151,248 New
151,248 $22.1 Million
Q3 2023

Nov 13, 2023
SELL
$146.04 - $225.78 $17 Million - $26.3 Million
-116,300 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$203.88 - $312.0 $3.95 Million - $6.05 Million
19,380 Added 16.7%
135,407 $31.3 Million
Q2 2023

Aug 14, 2023
SELL
$203.88 - $312.0 $22.3 Million - $34.2 Million
-109,506 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$231.06 - $307.08 $26.9 Million - $35.8 Million
116,591 New
116,591 $28.2 Million
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $6.79 Million - $34.5 Million
116,300 New
116,300 $33.8 Million
Q3 2022

Nov 13, 2023
BUY
$60.57 - $79.51 $7.04 Million - $9.25 Million
116,300 New
116,300 $7.56 Million
Q2 2022

Aug 14, 2023
BUY
$58.04 - $100.2 $6.36 Million - $11 Million
109,506 New
109,506 $7.84 Million
Q1 2022

May 12, 2023
SELL
$55.89 - $101.89 $379,716 - $692,240
-6,794 Reduced 5.84%
109,506 $10.7 Million
Q1 2022

May 09, 2022
SELL
$55.89 - $101.89 $6.12 Million - $11.2 Million
-109,506 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$72.34 - $95.09 $7.92 Million - $10.4 Million
109,506 New
109,506 $9.28 Million
Q3 2021

Nov 14, 2022
BUY
$78.35 - $105.02 $7.91 Million - $10.6 Million
101,006 New
101,006 $8.06 Million
Q3 2021

Nov 05, 2021
SELL
$78.35 - $105.02 $5.77 Million - $7.74 Million
-73,659 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$97.2 - $137.59 $7.16 Million - $10.1 Million
73,659 New
73,659 $7.18 Million
Q2 2021

Aug 10, 2021
SELL
$97.2 - $137.59 $10.4 Million - $14.7 Million
-106,566 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$108.54 - $125.2 $11.6 Million - $13.3 Million
106,566 New
106,566 $12.5 Million
Q1 2021

May 07, 2021
SELL
$108.54 - $125.2 $16.2 Million - $18.7 Million
-149,488 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$110.06 - $133.7 $16.5 Million - $20 Million
149,488 New
149,488 $16.6 Million
Q4 2020

Feb 10, 2021
SELL
$110.06 - $133.7 $17.6 Million - $21.3 Million
-159,482 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$99.78 - $124.21 $15.9 Million - $19.8 Million
159,482 New
159,482 $18.9 Million
Q3 2020

Nov 10, 2020
SELL
$99.78 - $124.21 $14.1 Million - $17.6 Million
-141,788 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$60.13 - $125.71 $8.53 Million - $17.8 Million
141,788 New
141,788 $16.1 Million
Q2 2020

Aug 07, 2020
SELL
$60.13 - $125.71 $7.98 Million - $16.7 Million
-132,652 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$66.76 - $93.49 $8.86 Million - $12.4 Million
132,652 New
132,652 $8.86 Million
Q1 2020

May 08, 2020
SELL
$66.76 - $93.49 $8.58 Million - $12 Million
-128,545 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$84.28 - $118.5 $10.8 Million - $15.2 Million
128,545 New
128,545 $11.7 Million
Q4 2019

Feb 12, 2020
SELL
$84.28 - $118.5 $7.32 Million - $10.3 Million
-86,899 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$84.4 - $106.53 $7.33 Million - $9.26 Million
86,899 New
86,899 $7.49 Million
Q3 2019

Nov 08, 2019
SELL
$84.4 - $106.53 $6.95 Million - $8.77 Million
-82,350 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$91.13 - $142.5 $7.5 Million - $11.7 Million
82,350 New
82,350 $8.63 Million
Q2 2019

Aug 09, 2019
SELL
$91.13 - $142.5 $7.5 Million - $11.7 Million
-82,350 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$94.77 - $215.54 $7.8 Million - $17.7 Million
82,350 New
82,350 $9.28 Million
Q4 2018

Feb 08, 2019
SELL
$94.77 - $215.54 $5.78 Million - $13.1 Million
-60,954 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$207.3 - $300.31 $12.6 Million - $18.3 Million
60,954 New
60,954 $13.1 Million

Others Institutions Holding MDGL

# of Institutions
296
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.94B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email